Skip to main content

Table 2 Laboratory investigations

From: Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation

Variable

All subjects (n = 97)

Low polyhedrocytes group (n = 14)

High polyhedrocytes group (n = 83)

p-value

Fibrinogen, g/L

3.31 ± 0.58

2.90 ± 0.46

3.38 ± 0.57

0.004

INR

1.00 (0.96–1.03)

1.02 (0.98–1.06)

0.99 (0.95–1.03)

0.22

aPTT, sec

25.00 (23.95–26.20)

24.75 (24.30–25.10)

25.10 (23.60–26.30)

0.80

WBC, 103/µL

6.93 ± 1.61

7.51 ± 1.62

6.83 ± 1.59

0.15

RBC,106/µL

4.64 (4.31–4.94)

4.62 (4.21–5.29)

4.64 (4.31–4.92)

0.82

HGB, g/dL

13.60 (12.90–14.50)

13.15 (11.98–14.33)

13.60 (13.00–14.50)

0.08

HCT, %

40.20 (38.70–42.90)

39.25 (36.30–42.43)

40.30 (38.70–42.90)

0.30

RDW, %

13.50 (13.00–14.50)

14.80 (13.00–15.90)

13.50 (12.90–14.40)

0.034

PLT 103/µL

204.00 (161.50–249.50)

207.50 (157.50–252.50)

204.00 (166.00–250.00)

0.87

PDW, fL

12.60 (11.40–14.50)

13.20 (11.40–14.80)

12.35 (11.38–14.50)

0.56

Glucose, mmol/L

6.60 (5.90–7.75)

5.70 (5.45–6.83)

6.60 (6.10–7.80)

0.018

HbA1c, %

6.40 (5.93–7.10)

6.50 (5.60–7.08)

6.40 (6.00–7.13)

0.78

Creatinine, µmol/L

82.00 (69.50–96.50)

81.00 (72.25–104.75)

82.00 (68.00–96.00)

0.72

eGFR (mL/min/1.73 m2)

76.97 ± 19.10

79.14 ± 22.79

76.60 ± 18.55

0.64

TC, mmol/L

3.93 (3.25–4.74)

3.69 (3.17–4.16)

4.08 (3.26–4.75)

0.30

LDL-C, mmol/L

2.19 (1.67–3.02)

1.79 (1.61–2.80)

2.26 (1.78–3.04)

0.31

HDL-C, mmol/L

1.22 (0.95–1.49)

1.24 (0.83–1.41)

1.22 (0.98–1.53)

0.78

TG, mmol/L

1.33 (1.03–1.73)

1.27 (0.98–2.09)

1.37 (1.03–1.73)

0.67

TSH, mIU/L

1.39 (0.84–2.05)

0.98 (0.88–1.88)

1.48 (0.84–2.12)

0.57

hsCRP, mg/L

2.29 (0.95–4.00)

1.35 (0.97–2.43)

3.02 (0.95–4.23)

0.11

  1. Values are given as mean ± SD or median (interquartile range)
  2. Low polyhedrocytes group represents lowest 10% of the observations. High polyhedrocytes group represents highest 90% of the observations
  3. aPTT activated partial thromboplastin time, eGFR estimated glomerular filtration rate based on a Modification of Diet in Renal Disease (MDRD) formula, HDL-C high-density lipoprotein cholesterol; HGB, hemoglobin, HCT hematocrit, hsCRP high sensitivity C-reactive protein, INR international normalized ratio, LDL-C low-density lipoprotein cholesterol, PDW platelet distribution width, RBC red blood cells, RDW red blood cell distribution width, PLT platelet count, TC total cholesterol, TG triglycerides, TSH thyroid-stimulating hormone, WBC white blood cells, ACEI angiotensin-converting-enzyme inhibitors, ARB angiotensin receptor blockers, BMI body mass index, MI myocardial infarction, T2D type 2 diabetes